NH TherAguix, a French clinical biotech specialized in the development of innovative nanomedicines for the treatment of cancer by radiotherapy, announces today the arrival of Aurélien Meyzaud as Head of Intellectual Property and Business Intelligence from January 2. With more than 15 years of experience in Intellectual Property, Competitive Intelligence…
Lire la suite...